Wikidata

(Q40111302)

English

Antitumor activity of a combination of trastuzumab (Herceptin) and oral fluoropyrimidine S-1 on human epidermal growth factor receptor 2-overexpressing pancreatic cancer

scientific article

In more languages

Statements

title
Antitumor activity of a combination of trastuzumab (Herceptin) and oral fluoropyrimidine S-1 on human epidermal growth factor receptor 2-overexpressing pancreatic cancer (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
17611667
retrieved
17 September 2017
author name string
Hiroyuki Saeki
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
17611667
retrieved
17 September 2017
Shunsuke Yanoma
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
17611667
retrieved
17 September 2017
Shouji Takemiya
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
17611667
retrieved
17 September 2017
Yukio Sugimasa
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
17611667
retrieved
17 September 2017
Makoto Akaike
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
17611667
retrieved
17 September 2017
Norio Yukawa
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
17611667
retrieved
17 September 2017
Yasushi Rino
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
17611667
retrieved
17 September 2017
Toshio Imada
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
17611667
retrieved
17 September 2017
publication date
1 August 2007
1 reference
stated in
Europe PubMed Central
PubMed ID
17611667
retrieved
17 September 2017
page(s)
433-439
1 reference
stated in
Europe PubMed Central
PubMed ID
17611667
retrieved
17 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40111302&oldid=1967244058"